Notice2024-02507
Notice of Award of a Sole Source Cooperative Agreement To Fund the Pan-American Health Organization (PAHO)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 7, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $8,000,000, with an expected total funding of approximately $50,000,000 over a 5-year period, to the Pan-American Health Organization (PAHO). The award will support strengthening immunization systems; ensuring polio free certification status; maintaining measles, rubella, and neonatal tetanus elimination; and prevention of other vaccine-preventable diseases (VPDs) in the Americas region. This award builds upon and continues work previously supported by PAHO through a cooperative agreement under CDC-RFA-GH-1901, "Cooperative Agreement with the Pan American Health Organization: Protecting and Strengthening Immunization Programs in the Americas."
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 26 (Wednesday, February 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 26 (Wednesday, February 7, 2024)]
[Notices]
[Pages 8433-8434]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02507]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
the Pan-American Health Organization (PAHO)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $8,000,000, with an expected total funding of
approximately $50,000,000 over a 5-year period, to the Pan-American
Health Organization (PAHO). The award will support strengthening
immunization systems; ensuring polio free certification status;
maintaining measles, rubella, and neonatal tetanus elimination; and
prevention of other vaccine-preventable diseases (VPDs) in the Americas
region. This award builds upon and continues work previously supported
by PAHO through a cooperative agreement under CDC-RFA-GH-1901,
``Cooperative Agreement with the Pan American Health Organization:
Protecting and Strengthening Immunization Programs in the Americas.''
DATES: The period for this award will be May 1, 2024, through April 30,
2029.
FOR FURTHER INFORMATION CONTACT: Mary A. Mulholland, (Global Health
Center, Centers for Disease Control and Prevention, 1600 Clifton Rd.
NE, Atlanta, GA 30333, Telephone: 404-553-7371, Email:
<a href="/cdn-cgi/l/email-protection#5f32322a33373033333e313b1f3c3b3c71383029"><span class="__cf_email__" data-cfemail="87eaeaf2ebefe8ebebe6e9e3c7e4e3e4a9e0e8f1">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The sole source award will establish a
cooperative agreement that will build upon the achievements of past
cooperative agreements with PAHO, while forging new collaborations to
strengthen the Expanded Program on Immunization in the Americas as a
[[Page 8434]]
whole. Supported activities will includes development of standards for
national immunization programs, development of national immunization
program capacity to prevent, detect and respond to VPDs, and maintain
the status of polio eradication; rubella, measles, and neonatal tetanus
elimination; and support the elimination of Hepatitis B. To achieve
these strategies, the recipient will provide direct technical
cooperation to Member States through both its regional headquarters and
country offices.
PAHO is in a unique position to conduct this work, as it functions
as the lead specialized health agency within the inter-American system
and operates as the regional office for the Americas on behalf of the
World Health Organization (WHO), the UN's specialized health agency,
with headquarters in Washington DC. Through their presence in the 35
member countries in the region, PAHO promotes technical cooperation
between countries and works in partnership with ministries of health
and other government agencies, civil society organizations, other
international agencies, universities, social security agencies,
community groups, and other partners. During nearly three decades of
partnership with CDC's Global Immunization Division, PAHO has made
outstanding progress towards strengthening routine immunization and
surveillance systems for polio, measles, rubella, and congenital
rubella syndrome; including maintaining the revolving fund for the bulk
purchase of vaccines for member countries; developing a strong platform
for strengthening surveillance of other VPDs; and maintaining its
polio-free certification since 1994, as well as verification of
regional rubella and CRS elimination since 2015 and regional measles
elimination since 2016.
Summary of the award:
Recipient: Pan-American Health Organization (PAHO).
Purpose of the Award: The purpose of this award is to support
strengthening immunization systems; ensuring polio free certification
status; maintaining measles, rubella, and neonatal tetanus elimination;
and prevention of other VPDs in the Americas region, in alignment with
the US Government endorsed Global Polio Eradication Initiative, the
Immunization Agenda 2030 and CDC's Global Immunization Strategic
Framework 2021-2030. Additionally, this NOFO supports CDC's Global
Health Strategy which focuses on protecting and improving the health,
safety, security, and well-being of Americans by reducing morbidity and
mortality worldwide; improving capabilities to prepare for and respond
to infectious diseases and other emerging health threats and public
health emergencies; and maximizing potential of CDC's global programs
to achieve public health impact.
Amount of Award: $8,000,000 in Federal fiscal year (FFY) 2024
funds, with a total estimated $ 50,000,000 for the 5-year period of
performance, subject to availability of funds. Funding amounts for
years 2-5 will be set at continuation.
Authority: This program is authorized under Section 307 of the PHS
Act (42 U.S.C 242); section 317(k)(1) and (2) of the PHS Act (42 U.S.C.
247b(k)(1) and (2).
Period of Performance: May 1, 2024, through April 30, 2029.
Dated: January 24, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Acting Chief Grants
Management Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02507 Filed 2-6-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.